Enzymit
EMEA
Rehovot
,
Israel
Startup
FOUNDED
2020
HEADCOUNT
21-100
FUNDING
Series A
Keywords:
enzymes, cell_free, biocatalysis, AI/ML, HTP_screening, hydrocolloids, prebiotics
BUSINESS
Enzymit is an Israeli cell-free biomanufacturing company founded in 2020 by Weizmann Institute alumni, headquartered in Ness Ziona, Israel. Enzymit has demonstrated pilot-scale (200 L) cell-free production of hyaluronic acid in partnership with Cosun, and is also targeting HMOs for infant nutrition
BIOTECH INVOLVEMENT
Core: AI-driven enzyme design platform for cell-free synthetic biology solutions. Enzymit uses deep learning and computational protein design to create novel, "new-to-nature" enzymes optimized for cell-free (non-fermentation) enzymatic cascade reactions. The platform explicitly bypasses whole-cell fermentation, instead using isolated enzyme catalysts engineered for high stability and reusability to synthesize target molecules like hyaluronic acid and HMOs.
TECHNOLOGY PLATFORM
AI computational protein design; deep learning; high-throughput screening
PRIMARY PRODUCTS
Novel enzymes and cell-free manufacturing processes for biochemicals and ingredients